Stem Cell Inc. Annual Revenues in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Stem Cell Inc. quarterly/annual Revenues history and growth rate from 2020 to 2022.
  • Stem Cell Inc. Revenues for the quarter ending September 30, 2023 was $0.000.
  • Stem Cell Inc. Revenues for the twelve months ending September 30, 2023 was $0.000.
  • Stem Cell Inc. annual Revenues for 2022 was $0.000.
  • Stem Cell Inc. annual Revenues for 2021 was $0.000.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.